Naut stock.
Nautilus Biotechnology Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-0.557 per share for the current fiscal year. Nautilus Biotechnology Inc does not currently pay a dividend.
NAUT was trading between about 4.50 and 5.00 this week. If Patel bought 250,000 shares this week (at market prices, not stock option exercises), then it must have cost him $1.1 million minimum.3 thg 8, 2021 ... ... Stock Information (OTCQX: TLNE) · SEC Filings · Leadership · Generation ... Nautilus Cryptomine will be powered via a direct interconnection to ...Proteomics at scale: Current approaches and emerging technologies. We outline the primary advantages and challenges of current proteomics technologies and discuss measures needed to enable quantification of the proteome at depths substantially greater than the 8-30% of the proteome that is readily accessible today. Proteomics and cancer.Their average twelve-month price target is $11.50, predicting that the stock has a possible upside of 34.66%. The high price target for NAUT is $13.00 and the low price target for NAUT is $10.00. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus rating of "Buy."A high-level overview of Nautilus Biotechnology, Inc. (NAUT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Holder Shares Date Reported % Out Value; Vanguard Total Stock Market Index Fund: 1,742,974: Jun 29, 2023: 1.40%: 6,745,309: iShares Russell 2000 ETF: 1,116,218 Get the latest news, data and filings for Nautilus Biotechnology (NAUT), with free alerts. Includes transcripts, social sentiment, and more.
Get the latest Nautilus Biotechnology, Inc. (NAUT) stock news and headlines to help you in your trading and investing decisions.
See NAUT Report. The 73 rating InvestorsObserver gives to Nautilus Biotechnology Inc ( NAUT) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 85 percent of stocks in the Healthcare sector, NAUT’s 73 overall rating means the stock scores better than 73 of all stocks. NAUT has an Overall Score of 73.About NioCorp Developments Stock (OTCMKTS:NIOBF) NioCorp Developments Ltd. operates as a development stage company. It engages in the acquisition, exploration, and development of mineral properties. The company is headquartered in Centennial, CO. Read More.0.55. EBIT. -57.92. -50.32. -15.62. -9.62. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for Nautilus Biotechnology, Inc. (NAUT). See many years of revenue ...提供今日Nautilus Biotechnology (NAUT)行情数据，包括价格，各周期走势图，基本资料及实时新闻资讯，财务分析，公司介绍，分红派息信息，您还可使用Moomoo开户 ...Explore NAUT - Nautilus Biotechnology Inc Stock Price Forecast: Accurate short-term and long-term price predictions up to 2050
Overview News Ideas Financials Technicals Forecast NAUT chart Today1.07% 2.53% 1 month 6 months2.16% Year to date57.78% 1 year63.22% 5 years−75.28% −75.28% Key …
Nov 24, 2023 · Nautilus Biotechnology (NAUT) Insider Trading Activity 2023. S&P 500 4,559.34. DOW 35,390.15. QQQ 389.51. 12 crew members are missing, 1 dead after a cargo ship sinks off a Greek island in stormy seas. [Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad) Turned down for a loan, business owners look to family and even ...
Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022. (GlobeNewswire) May-12-22 06:28AM. Trade Alert: The Co-Founder Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT), Sujal Patel, Has Just Spent US$198k Buying A Few More Shares. (Simply Wall St.) +6.81%. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.With 33% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future. Key Insights Significant insider control over Nautilus Biotechnology implies ...Nautilus Biotechnology Inc stock performance at a glance Check Nautilus Biotechnology Inc’s past financial performance, like revenue or net income, plus the top level summary …Overview Key Ratios Trading Information Last Close 3.02 Sector Healthcare Industry Biotechnology Investment Style Small Value Day Range 2.94 – 3.08 Year …
Nautilus Biotechnology Inc () Stock Market info Recommendations: Buy or sell Nautilus Biotechnology stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Nautilus Biotechnology share forecasts, stock quote and buy / sell signals below.According to present data Nautilus Biotechnology's NAUT shares and potentially …... Nautilus at Zeigler Lincoln of Kalamazoo, you may have a visceral ... ‡Vehicles shown at different locations are not currently in our inventory (Not in Stock) ...NUSMF - Nautilus Minerals Inc Stock - Stock Price, Institutional Ownership, Shareholders (OTC)Equipment, reagents and lab consumables may be managed including equipment service and calibration records and lab consumable inventory tracking and data such ...View NAUT: Nautilus Biotechnologyinvestment & stock information. Get the latest NAUT: Nautilus Biotechnology detailed stock quotes, stock data, Real-Time ECN, charts, stats and more..
Nautilus Biotechnology to Announce Second Quarter 2022 Financial Results on August 2, 2022. (GlobeNewswire) May-12-22 06:28AM. Trade Alert: The Co-Founder Of Nautilus Biotechnology, Inc. (NASDAQ:NAUT), Sujal Patel, Has Just Spent US$198k Buying A Few More Shares. (Simply Wall St.) +6.81%.NAUT, a company in the Health Technology sector, specifically in the Biotechnology industry, has a market capitalization of $296.1 million. The company’s earnings growth in the last year was positive, with an increase of 21.96%. However, the current year’s earnings growth has seen a decline of 49.46%.
... stock (6) In stock (6 products); Out of stock (5) Out of stock (5 products) ... Blemished Nautilus Scales. Add to wishlist Remove from wishlist. Blemished Nautilus ...NAUT U.S.: Nasdaq Nautilus Biotechnology Inc. Watch list Set a price target alert After Hours Last Updated: Nov 28, 2023 4:11 p.m. EST Delayed quote $ 2.8100 0.00 0.00% After Hours Volume: 1.81K...Hindustan Aeronautics Ltd., incorporated in the year 1963, is a Large Cap company (having a market cap of Rs 164,669.12 Crore) operating in Defence sector. Hindustan Aeronautics Ltd. key Products/Revenue Segments include Sale of services, Spares And Others, Engineering Goods, Development Projects ...SEATTLE, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the expansion of its research and development senior leadership team with the appointment of Martin Huber, Ph.D., as Vice President of …With 33% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot riding on the company's future. Key Insights Significant insider control over Nautilus Biotechnology implies ...Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.2,251,845. 270,064. 8.33819. Back to NAUT Overview. NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid ...Morgan Stanley Lowers Nautilus Biotechnology's Price Target to $6 From $8, Maintains Equalweight Rating. 2022. MT. Goldman Sachs Adjusts Nautilus Biotechnology's Price Target to $4 from $5, Keeps Neutral Rating. 2022. MT. Goldman Sachs Adjusts Nautilus Biotechnology's Price Target to $5 from $9, Keeps Neutral Rating.
Nautilus Biotechnology Inc. Annual stock financials by MarketWatch. View the latest NAUT financial statements, income statements and financial ratios.
05/02/2023 - 06:30 AM . SEATTLE, May 02, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single molecule proteome analysis platform, today reported financial results for the first quarter ended March 31, 2023.
Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Nautilus Biotechnology Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 3.00. The ...Equipment, reagents and lab consumables may be managed including equipment service and calibration records and lab consumable inventory tracking and data such ...The average trading volume of NAUT on November 14, 2023 was 82.37K shares. NAUT) stock’s latest price update. The stock of Nautilus Biotechnology Inc (NASDAQ: NAUT) has increased by 15.09 when compared to last closing price of 2.65.Despite this, the company has seen a gain of 24.49% in its stock price over the last five trading days.total yearly compensation is $1.76M, comprised of 28.4% salary and 71.6% bonuses, including company stock and options. directly owns 13.69% of the company’s shares, worth $50.56M. The average tenure of the management team and the board of directors is 2.4 years and 2.4 years respectively.NAUT Vs NGG: Stock comparison by Artificial Intelligence. Which is a better buy? Make smart data-driven investment decisions and get unique insights. Start now and save 50% for the first 3 months save 50% for the first 3 months. Ticker. Company. Your search produced no matches.On March 18, 2014, Bruce Cazenave, CEO of Nautilus, Inc., rang the New York Stock Exchange's opening bell. Nautilus, Inc. also featured its new home fitness ...Nautilus Biotechnology Inc. (NAUT) Since the beginning of 2023, Nautilus Biotechnology has been on the move. Shares have climbed from around $1.80 to over $2.30 during that time, and the latest bump took NAUT stock back above its 200-day moving average for the first time since the stock traded long enough actually to have a 200DMA.Get Nautilus Biotechnology Inc (NAUT.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsNautilus Defense rapidly develops and builds state of the art multifunctional textile systems to provide unmatched deployable, wearable, and embeddable ...Nautilus Biotechnolgy, Inc. Common Stock (NAUT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Nautilus Biotechnology (NASDAQ:NAUT) goes in the spotlight today. The company has moved closer to its commercial launch date since we first wrote about this name more than a year ago ...
The company was granted 4 new US Patents in the first quarter of 2023, raising Nautilus’ total to 12 granted US Patents. Total operating expenses for the first quarter of 2023 were $18.1 million, up $2.1 million compared to the first quarter of 2022 and $1.8 million above last quarter. “In Q1 we continued to make steady progress in ...The new Nautilus SUV enters its second generation with major changes, including a new hybrid powertrain in place of its previous twin-turbo V-6.Nautilus Marine Services PLC Frequently Asked Questions. What is Nautilus Marine Services PLC (LSE:NAUT)'s stock price today? The current price of LSE:NAUT is £0.01. The 52 week high of LSE:NAUT is £0.09 and 52 week low is £0.01. When is next earnings date of Nautilus Marine Services PLC (LSE:NAUT)?The public float for NAUT is 52.94M, and currently, short sellers hold a 2.47% ratio of that float. The average trading volume of NAUT on November 07, 2023 was 78.58K shares. NAUT’s Market Performance. NAUT stock saw a decrease of 4.70% in the past week, with a monthly decline of -18.87% and a quarterly a decrease of -21.22%.Instagram:https://instagram. otcmkts tcnnf comparecybnamerican quarter dollar coin valuespenny stock apps The ticker will change to NAUT on Thursday morning. Editor’s note: NAUT shares ended Thursday at $11.00. ... also known as a common stock PIPE, which is used to fuel a SPAC as an extra financing ... zs stocksgoro NAUT U.S.: Nasdaq Nautilus Biotechnology Inc. Watch list Set a price target alert After Hours Last Updated: Nov 28, 2023 4:11 p.m. EST Delayed quote $ 2.8100 0.00 0.00% After Hours Volume: 1.81K... fake stocks screen Morgan Stanley Lowers Nautilus Biotechnology's Price Target to $6 From $8, Maintains Equalweight Rating. 2022. MT. Goldman Sachs Adjusts Nautilus Biotechnology's Price Target to $4 from $5, Keeps Neutral Rating. 2022. MT. Goldman Sachs Adjusts Nautilus Biotechnology's Price Target to $5 from $9, Keeps Neutral Rating. NAUT Stock Analysis Overview. What this means: Nautilus Biotechnology Inc (NAUT) gets an Overall Rank of 56, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked …